生物技术企业 meaning in Chinese
biobusiness
Examples
- Companies in the medical and biotechnology fields are concentrated there as well
此外，还集中了大量的医疗和生物技术企业。 - Shizuoka prefecture has launched its fuji pharma valley initiatives to form a cluster of medical , healthcare and biotechnology companies at the base of mt . fuji
静网县已经启动了自己的富士医药谷计划，以在富士山脚下形成一个医疗保健和生物技术企业集群。 - The fuji pharma valley initiative is designed to foster a more intensive concentration of medical , healthcare and biotechnology companies , principally in eastern shizuoka prefecture , by invigorating existing industries and creating new ones
富士医药谷计划旨在通过振兴现有的产业创建新的产业，促进医疗健康和生物技术企业的集群，主要是在静网县的东部地区。 - We should use this chance , establish an appropriate strategy and improve the innovation abilities of corporations . the long - term strategic target is to use about 10 years to complete the research for new medicines and then shift to " independent research and development " ; to be in the top level of the world for innovative research and development of new technology and new products in the biopharmaceutical industry ; to make china become the leading center for biotech innovation ; to set up an innovative mechanism with corporations to be the core body and relevant to the international competing situation and self developing disciplines of modern corporations ; to bring up a batch of entities with competing capacities in the market and independent exploitation abilities ; to be a leading country with great power in biotech industry . joint exploitation , improvement and innovation , dividing market into even smaller fractions , and cost minimization are the main conditions for realizing the strategic target
本论文从分析国内外生物技术企业的发展环境和发展特点入手，阐述我国生物技术企业加强科技创新的重要性和可行性，结合国情现状研究我国生物技术企业的科技创新战略，提出我国医药生物技术产业的长期战略目标应该是“用十年左右的时间，完成新药研究向"自主研发"的转移，在新技术、新产品的创新性研发方面跻身世界医药生物技术产业的领先行列，将中国建设成为世界一流的生物技术创新中心，建立健全以企业为核心的适应国际医药竞争形势和现代企业自身发展规律的技术创新运行机制体系，培养一批具有市场竞争力和自主开发能力的骨干创新实体，成为世界生物技术产业强国" 。